Vascular endothelial dysfunction and pharmacological treatment
about
At the interface of antioxidant signalling and cellular function: Key polyphenol effectsTreating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola.Role of circulating factors in cardiac aging.Angiotensin receptors and β-catenin regulate brain endothelial integrity in malaria.Modeling Disease Progression: Angiotensin II Indirectly Inhibits Nitric Oxide Production via ADMA Accumulation in Spontaneously Hypertensive Rats.Nitric Oxide: Exploring the Contextual Link with Alzheimer's DiseaseEndothelial Dysfunction and Hypertension.Heme Oxygenase-1 and Carbon Monoxide in the Heart: The Balancing Act Between Danger Signaling and Pro-Survival.Mechanistic insights into the vascular effects of blueberries: Evidence from recent studies.Nucleic Acid Delivery for Endothelial Dysfunction in Cardiovascular DiseasesTert-butyl hydroperoxide (t-BHP) induced apoptosis and necroptosis in endothelial cells: Roles of NOX4 and mitochondrion.Vascular inter-regulation of inflammation: molecular and cellular targets for CNS therapy.Redox status of patients before cardiac surgery.Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment.Pulmonary hypertension: Molecular aspects of current therapeutic intervention and future direction.Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets.Age-Dependent Decrease in Adropin is Associated with Reduced Levels of Endothelial Nitric Oxide Synthase and Increased Oxidative Stress in the Rat Brain.Epidemiology and Immune Pathogenesis of Viral SepsisThe effect of far infrared radiation therapy on inflammation regulation in lipopolysaccharide-induced peritonitis in mice
P2860
Q28071627-C1C285E4-EDE4-4C4A-A450-2C6F3982AFC0Q28076034-DF295977-0CFE-4432-9B7B-2331E4EB0A82Q30234641-CCD5FD03-4B46-419D-9412-B62DC9A1A665Q37395730-4280DE30-F715-4293-AC3E-FCB8AB783DA6Q37418608-E3B9CF8F-C16A-47CE-85D2-399C5E0AC43CQ37554157-0EA4F264-3F76-426B-B6B0-31A4997D3824Q38776339-BB1CE4B1-1033-49B0-AD35-12D33F766A9BQ38860810-D16E6E08-FE18-406C-847D-D725102F58A9Q38936724-F917D162-A5DE-432F-B607-0A90FCA44C13Q39003359-7852C310-08B1-4CB6-BB7C-1B15EB634A74Q39020249-7BB6FDA5-226A-421D-B6A1-F889379E28E7Q39031301-99DD01E7-38EF-4B25-B659-DB5898458828Q46236592-8D49A641-2B77-451E-996A-A05B8CAE4048Q47557757-EB3C4685-F365-4B5F-87B2-05A8A10433E5Q47941425-99A5CC55-C611-4D99-9EC6-B1AD55A3BBCDQ48512017-50DC0B4C-43E0-4C45-8B71-5D0D9C1C5860Q55114131-CC8CEC1B-7FDB-4090-817B-A7105CF821C9Q57490857-917DEFA6-4F32-4E2D-9514-2DD084C18A3CQ58756203-10E9D17B-D9A2-41C3-BBFC-38F71CA8CB9E
P2860
Vascular endothelial dysfunction and pharmacological treatment
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Vascular endothelial dysfunction and pharmacological treatment
@ast
Vascular endothelial dysfunction and pharmacological treatment
@en
Vascular endothelial dysfunction and pharmacological treatment
@nl
type
label
Vascular endothelial dysfunction and pharmacological treatment
@ast
Vascular endothelial dysfunction and pharmacological treatment
@en
Vascular endothelial dysfunction and pharmacological treatment
@nl
prefLabel
Vascular endothelial dysfunction and pharmacological treatment
@ast
Vascular endothelial dysfunction and pharmacological treatment
@en
Vascular endothelial dysfunction and pharmacological treatment
@nl
P2860
P356
P1476
Vascular endothelial dysfunction and pharmacological treatment
@en
P2860
P304
P356
10.4330/WJC.V7.I11.719
P407
P50
P577
2015-11-26T00:00:00Z